High glucose-induced downregulation of connexin 30.2 promotes retinal vascular lesions: Implications for diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 3, 2013, Pages 2361-2366

  Manasson, Julia ^a   Tien, Thomas ^a   Moore, Colleen ^a   Kumar, Nalin M ^b   Roy, Sayon ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 30; GLUCOSE; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL COMMUNICATION; CELL CULTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOWN REGULATION; ENDOTHELIUM CELL; GAP JUNCTION; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA INJURY; VASCULAR LESION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CONNEXINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCOSE; MICE; MICE, KNOCKOUT; RATS; RETINA;

EID: 84875641085     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10815     Document Type: Article

References (30)

1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-136.
2. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
3. Porta M, Allione A. Current approaches and perspectives in the medical treatment of diabetic retinopathy. Pharmacol Ther. 2004;103:167-177.
4. Durham JT, Herman IM. Microvascular modifications in diabetic retinopathy. Curr Diab Rep. 2011;11:253-264.
5. Li AF, Roy S. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2009;50:1400-1407.
6. Kumar NM, Gilula NB. The gap junction communication channel. Cell. 1996;84:381-388.
7. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res. 2004;62:228-232.
8. Bedner P, Steinhauser C, Theis M. Functional redundancy and compensation among members of gap junction protein families? Biochim Biophys Acta. 2011;1818:1971-1984.
9. Oku H, Kodama T, Sakagami K, Puro DG. Diabetes-induced disruption of gap junction pathways within the retinal microvasculature. Invest Ophthalmol Vis Sci. 2001;42:1915-1920.
10. Figueroa XF, Duling BR. Gap junctions in the control of vascular function. Antioxid Redox Signal. 2009;11:251-266.
11. Hill CE, Rummery N, Hickey H, Sandow SL. Heterogeneity in the distribution of vascular gap junctions and connexins: implications for function. Clin Exp Pharmacol Physiol. 2002; 29:620-625.
12. Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Ophthalmol Vis Sci. 2010;51:3758-3763.
13. Janssen-Bienhold U, Dermietzel R, Weiler R. Distribution of connexin43 immunoreactivity in the retinas of different vertebrates. J Comp Neurol. 1998;396:310-321.
14. Roy S, Trudeau K, Behl Y, Dhar S, Chronopoulos A. New insights into hyperglycemia-induced molecular changes in microvascular cells. J Dent Res. 2010;89:116-127.
15. Sohl G, Guldenagel M, Traub O, Willecke K. Connexin expression in the retina. Brain Res Brain Res Rev. 2000;32: 138-145.
16. Muller LP, Dedek K, Janssen-Bienhold U, et al. Expression and modulation of connexin 30.2, a novel gap junction protein in the mouse retina. Vis Neurosci. 2010;27:91-101.
17. Nielsen PA, Kumar NM. Differences in expression patterns between mouse connexin-30.2 (Cx30.2) and its putative human orthologue, connexin-31.9. FEBS Lett. 2003;540:151-156.
18. Li AF, Sato T, Haimovici R, Okamoto T, Roy S. High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes. Invest Ophthalmol Vis Sci. 2003;44:5376-5382.
19. Sato T, Haimovici R, Kao R, Li AF, Roy S. Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes. 2002;51: 1565-1571.
20. Suadicani SO, Urban-Maldonado M, Tar MT, Melman A, Spray DC. Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int. 2009;103: 1686-1693.
21. Ball KK, Harik L, Gandhi GK, Cruz NF, Dienel GA. Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications. J Neurosci Res. 2011;89:2052-2067.
22. Zanetta L, Marcus SG, Vasile J, et al. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer. 2000;85:281-288.
23. Chronopoulos A, Trudeau K, Roy S, Huang H, Vinores SA. High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy. Curr Eye Res. 2011;36:747-753.
24. Oshitari T, Polewski P, Chadda M, Li AF, Sato T, Roy S. Effect of combined antisense oligonucleotides against high-glucose-and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes. 2006; 55:86-92.
25. el-Fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res. 1987;168:422-430.
26. Roy S, Nasser S, Yee M, Graves DT. A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats. Mol Vis. 2011;17:3166-3174.
27. Fernandes R, Girao H, Pereira P. High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasomedependent mechanism. J Biol Chem. 2004;279:27219-27224.
28. Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011;52:1156-1163.
29. Gemel J, Lin X, Collins R, Veenstra RD, Beyer EC. Cx30.2 can form heteromeric gap junction channels with other cardiac connexins. Biochem Biophys Res Commun. 2008;369:388-394.
30. Giardina SF, Mikami M, Goubaeva F, Yang J. Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis. Biochem Biophys Res Commun. 2007;362:747-752.